SCHEMBL3520926

SCHEMBL3520926

CCc1c(-c2ncc[nH]2)c2cc3nc(cc4ccc(cc5nc(cc1[nH]2)C=C5)[nH]4)C=C3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NISCH Q9Y2I1 2/20 0.32
▸ PDE4A P27815 1/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ STAT3 P40763 1/20 0.31
▸ STAT1 P42224 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ TAAR1 Q96RJ0 1/20 0.31
▸ MTOR P42345 1/20 0.30
▸ ADK P55263 1/20 0.30
▸ IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2963034 0.88 NISCH (0.36) NISCHPDE4APDE4BPDE4CPDE4D
SCHEMBL3520923 0.81 STAT3 (0.42) ADORA2AADORA1STAT3STAT1
SCHEMBL3522525 0.80 CBFB (0.40) MTOR
SCHEMBL3556863 0.78 TLR9 (0.33) —
SCHEMBL2955031 0.76 STAT3 (0.52) NISCHSTAT3STAT1MTORADK
SCHEMBL10433085 0.75 STAT3 (0.32) STAT3STAT1
SCHEMBL8986469 0.75 STAT3 (0.32) STAT3STAT1
SCHEMBL2963039 0.75 STAT3 (0.50) NISCHSTAT3STAT1MTORADK
SCHEMBL2955029 0.74 IDO1 (0.36) NISCHSTAT3STAT1MTORADK
SCHEMBL2962139 0.73 IDO1 (0.35) NISCHSTAT3STAT1MTORADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718201-B1 SUBSTITUTED PORPHYRINS UNIV DUKE (US) 2016-09-14 — — EP disclosed
US-20150344509-A1 SUBSTITUTED PORPHYRINS UNIV DUKE (US) 2015-12-03 — — US disclosed
US-9096628-B2 Substituted porphyrins DUKE UNIVERSITY (US) 2015-08-04 — — US disclosed
US-20140080797-A1 SUBSTITUTED PORPHYRINS DUKE UNIVERSITY (US) 2014-03-20 — — US disclosed
US-8618089-B2 Substituted porphyrins DUKE UNIVERSITY (US) 2013-12-31 — — US disclosed
US-20120264725-A1 SUBSTITUTED PORPHYRINS BATINIC-HABERLE INES (US) 2012-10-18 — — US disclosed
US-8183364-B2 Substituted porphyrins DUKE UNIVERSITY (US) 2012-05-22 — — US disclosed
US-20100305083-A1 SUBSTITUTED PORPHYRINS BATINIC-HABERLE INES 2010-12-02 — — US disclosed
US-7807825-B2 Substituted porphyrins DUKE UNIVERSITY (US) 2010-10-05 — — US disclosed
US-20080021007-A1 Substituted Porphyrins NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344509-A1 SUBSTITUTED PORPHYRINS PPOX, FECH, MB ADORA2A 4821/4885ADORA1 4813/4885CYP1A2 2554/4885
US-20120264725-A1 SUBSTITUTED PORPHYRINS PPOX, FECH, MB ADORA2A 4821/4885ADORA1 4813/4885CYP1A2 2554/4885
US-20080021007-A1 Substituted Porphyrins SOD3, SOD1, PRDX3 ADORA2A 4699/4885ADORA1 4865/4885CYP1A2 3288/4885
US-20140080797-A1 SUBSTITUTED PORPHYRINS PPOX, FECH, MB ADORA2A 4821/4885ADORA1 4813/4885CYP1A2 2554/4885
US-20100305083-A1 SUBSTITUTED PORPHYRINS SOD3, SOD1, PRDX3 ADORA2A 4740/4885ADORA1 4866/4885CYP1A2 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback